Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Government is still supported most by it amount of pay to do my assignment.

Popular Articles

Ban on Entry load cuts churn in MF schemes
The ban on entry load (the fees charged from investors for entering a scheme) has brought some sanity in mutual fund (MF) distribution. The move has ensured a drastic reduction in portfolio churning from the levels seen in 2006-07.

Kalpataru Power declines despite bagging orders
Kalpataru Power Transmission closed at Rs 1151, weaker by Rs 19 or 1.64%, on the BSE.

News of the day

ASE plans to tie up with NSE
Gujarat’s Ahmedabad Stock Exchange (ASE) plans to tie up with the country’s top equity bourse, the National Stock Exchange (NSE), say sources within ASE.
Online Business

Matrix assigns its right to buy Astrix stake to Mylan unit

Matrix Laboratories Ltd, a subsidiary of the US-based generics drugmaker, Mylan lnc, has assigned its right to purchase 1 per cent equity in Astrix Laboratories Ltd to Mylan Luxembourg, another subsidiary of Mylan. - Matrix is main supplier to Clinton AIDS plan - Matrix Labs gets US FDA approval for ARVs - Matrix surges 20% on delisting plans - Matrix Labs surges 20% on delisting offer - Praj develops innovative method to produce ethanol - Debate: Do India"s audit rules need to be overhauled? Astrix is an India-based 50:50 joint venture between Matrix and Aspen Pharmacare Holdings Ltd of South Africa. Earlier, Matrix and Aspen had signed an agreement which said that Aspen would divest its stake in Astrix to Matrix. In January 2009, Matrix announced the assignment of a portion of its right to acquire Aspen"s stake in Astrix to MP Laboratories (Mauritius) Ltd, a wholly-owned subsidiary of Mylan. Pursuant to this assignment, MP Labs has to purchase Aspen’s stake in Astrix to the extent of 49 per cent and Matrix has to purchase the remaining 1 per cent, thereby increasing its stake in the joint venture to 51 per cent. As part of its planned growth strategy, Matrix had agreed to purchase the 49 per cent equity shares in Astrix from MP Labs within a two-year period. With this, Astrix would be wholly-owned by Matrix. However, Matrix stated in a release that obtaining regulatory approvals for acquiring a majority stake in Astrix was taking time. Hence, it had signed the right to acquire the balance 1 per cent in Astrix to Mylan Luxembourg. After regulatory approvals, Matrix would purchase this stake from the Luxembourg wholly-owned outfit of Mylan. Mylan Inc, which currently holds 71.2 per cent in Matrix through MP Laboratories (Mauritius) Ltd, came out with a public offer in the first week of this month to buy back the remaining 24.8 per cent equity in Matrix at an indicative price of Rs 150 per share. Mylan plans to delist the Indian drug maker from the domestic bourses following the buyback. After the buyback, Matrix would become a wholly-owned subsidiary of Mylan.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009